FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Animal Drugs

Therivas Pancreatic Cancer Drug Hits Endpoints

Theriva Biologics reports positive Phase 2b VIRAGE topline results for its VCN-01 when added to standard of care chemotherapy to treat a form of pancr...

Biologics

Moderna Flu/Covid Vaccine Beats Comparators: Study

A Moderna Phase 3 study says its combination mRNA flu and Covid-19 vaccine achieved a greater immune response than comparator standard of care vaccine...

Human Drugs

Omeros BLA Resubmission for Narsoplimab

FDA accepts for review an Omeros BLA resubmission for narsoplimab for treating hematopoietic stem cell transplant-associated thrombotic microangiopath...

latest-news-card-1
FDA General

Bill Would Create FDA Inspector General

Sen. Eric Schmitt introduces legislation to create an inspector general for FDA and two other public health agencies.

latest-news-card-1
Human Drugs

Oncologic Panel to Review 4 Cancer Submissions

FDA announces a 5/20-21 Oncologic Drugs Advisory Committee meeting to review and vote on four cancer drug submissions.

latest-news-card-1
Biologics

FDA Panel to Mull Covid Vaccine Strain Selection

FDA announces a 5/22 Vaccines and Related Biological Products Advisory Committee meeting to discuss and make recommendations on the selection of the 2...

latest-news-card-1
Human Drugs

Amicis Research Didnt Follow Investigation Plan: FDA

FDA warns Dr. Nana Barseghian about a bioresearch monitoring violation in a clinical trial at Northridge, CA-based Amicis Research Center.

latest-news-card-1
Human Drugs

Trump Administration Seeks Mifepristone Case Dismissal

The Trump administration asks a federal judge to dismiss a lawsuit filed by three GOP states that seeks to block access to the abortion pill mifeprist...

latest-news-card-1

More Unannounced Foreign Inspections Coming

FDA says it is expanding the use of unannounced inspections of foreign medical product and food manufacturing facilities.

latest-news-card-1
Human Drugs

FDA Ordered to Speed U.S. Drug Manufacturing

President Trump signs an Executive Order requiring FDA to take steps to increase domestic drug manufacturing.